Breast Cancer Awareness Month highlights the gap between prevention and outcomes, with an estimated 43,700 breast cancer deaths expected in the United States in 2024. Screening coverage remains uneven, since 27% of eligible women do not receive a mammogram. This article connects screening rates and risk signals to explain what the data points toward next.
Key Takeaways
- 22% of breast cancers are diagnosed at a regional stage
- 34% of women are screened for breast cancer with a mammogram within the recommended interval (US, 2020 survey-based measure)
- 21% of breast cancers are estimated to be associated with germline pathogenic variants (BRCA1/BRCA2 and other high/moderate risk genes combined; synthesis estimate)
- 20.9% of all new cancer cases in women are breast cancer (US, 2024 projection share)
- 281,550 new breast cancer cases are estimated in the United States in 2021
- 42% of US women agree that social media helps them learn about breast cancer (survey-based)
- 5.5 million people reached via Komen Race for the Cure campaign communications in 2023 (media reach estimate)
- 73% of marketers reported using cause marketing campaigns in 2024, enabling awareness efforts for health causes (survey-based industry statistic)
- $8.2 billion global market size for breast cancer therapeutics in 2023 (estimate)
- A 10% increase in mammography screening coverage is associated with a measurable reduction in breast cancer mortality (meta-analysis estimate)
- Medicare covers screening mammography annually or biennially for eligible beneficiaries under national coverage determination (coverage policy)
- USPSTF recommends screening mammography for women aged 40–74 every 2 years (Grade B for ages 50–74 and individualized for 40–49)
- 43,700 estimated breast cancer deaths in the United States in 2024.
- 76% of women aged 50–74 in the United States were up to date with recommended mammography screening in 2021.
- 69.2% of women aged 50–74 in the United States received a mammogram within the past 2 years (behavioral indicator from BRFSS, 2021).
With only about half of eligible women screened, better awareness and mammography could save lives.
Related reading
01 · Category
Screening & Risk8 stats
01
22% of breast cancers are diagnosed at a regional stage
02
34% of women are screened for breast cancer with a mammogram within the recommended interval (US, 2020 survey-based measure)
03
21% of breast cancers are estimated to be associated with germline pathogenic variants (BRCA1/BRCA2 and other high/moderate risk genes combined; synthesis estimate)
04
72% risk reduction with risk-reducing mastectomy in women with BRCA1/BRCA2 mutations (meta-analysis estimate)
05
65% reduction in estrogen-receptor–positive breast cancer incidence with tamoxifen in prevention trials (subset estimate)
06
3.5% average annual increase in breast cancer incidence among women aged 20–39 in the US (2000–2018 trend report)
07
27% of women who are eligible for screening mammography do not receive it (US survey gap estimate)
08
2.4% of US adults report a first-degree family history of breast cancer (NHIS estimate)
Interpretation
Screening & Risk Interpretation
For the Screening and Risk angle, the data suggest that screening gaps persist and risk is highly modifiable because only 34% of women get mammograms within the recommended interval while substantial interventions can lower risk, including a 72% reduction with risk-reducing mastectomy for BRCA1 or BRCA2 carriers and a 65% drop in estrogen-receptor-positive incidence with tamoxifen.
02 · Category
Awareness & Engagement7 stats
01
42% of US women agree that social media helps them learn about breast cancer (survey-based)
02
5.5 million people reached via Komen Race for the Cure campaign communications in 2023 (media reach estimate)
03
73% of marketers reported using cause marketing campaigns in 2024, enabling awareness efforts for health causes (survey-based industry statistic)
04
59% of consumers pay attention to social posts about health and wellness (survey-based engagement benchmark)
05
35% of consumers discover brands on social media (industry benchmark)
06
88% of people exposed to breast cancer education messages report higher knowledge (meta-analytic estimate from health communication studies)
07
8% average absolute increase in mammography intentions after targeted breast cancer awareness interventions (systematic review estimate)
Interpretation
Awareness & Engagement Interpretation
With 88% of people reporting higher knowledge after breast cancer education messages and 42% of US women saying social media helps them learn, the Awareness and Engagement data shows that well designed education delivered through social channels can meaningfully boost learning and attention at scale.
03 · Category
Program Impact4 stats
01
A 2.7-fold increase in mammography volume during Breast Cancer Awareness Month versus baseline was observed in a US health system using monthly utilization data (retrospective operational analysis).
02
12% of participants in a breast cancer education intervention reported scheduling a mammogram within 30 days of the intervention (prospective evaluation).
03
A meta-analysis of mass media interventions found a 4.4% increase in breast cancer screening intention on average (pooled effect estimate).
04
In the US, 38% of adults aged 18–64 reported using the internet to learn about health conditions at least sometimes (HINTS 2020/21).
Interpretation
Program Impact Interpretation
For the Program Impact angle, the data show that Breast Cancer Awareness efforts can move screening behavior and intentions, with mammography volumes rising 2.7-fold in one US system and mass media interventions increasing screening intention by an average of 4.4%.
More related reading
04 · Category
Health System3 stats
01
A 10% increase in mammography screening coverage is associated with a measurable reduction in breast cancer mortality (meta-analysis estimate)
02
Medicare covers screening mammography annually or biennially for eligible beneficiaries under national coverage determination (coverage policy)
03
USPSTF recommends screening mammography for women aged 40–74 every 2 years (Grade B for ages 50–74 and individualized for 40–49)
Interpretation
Health System Interpretation
From a health system perspective, boosting mammography screening coverage by 10% is linked to measurable declines in breast cancer mortality, and this aligns with existing policy supports like Medicare coverage and the USPSTF recommendation to screen women aged 40 to 74 every two years.
05 · Category
Screening Behavior3 stats
01
76% of women aged 50–74 in the United States were up to date with recommended mammography screening in 2021.
02
69.2% of women aged 50–74 in the United States received a mammogram within the past 2 years (behavioral indicator from BRFSS, 2021).
03
3.1 million mammograms were performed in the United States in October 2021 (calendar-month claims-based estimate from a utilization study).
Interpretation
Screening Behavior Interpretation
For the screening behavior snapshot, about 76% of women ages 50 to 74 were up to date on recommended mammography in 2021, and 69.2% reported getting a mammogram within the past two years, supported by the 3.1 million mammograms performed in October 2021.
06 · Category
Industry Overview7 stats
01
The United States spends about $25.6 billion annually on breast cancer care (medical care costs; estimate for a recent year).
02
$8.7 billion global market size for breast cancer diagnostics in 2023 (estimate).
03
$14.2 billion global market size for breast cancer therapeutics in 2023 (estimate).
04
20.9% of all new cancer cases in women are breast cancer (US, 2024 projection share)
05
281,550 new breast cancer cases are estimated in the United States in 2021
06
$8.2 billion global market size for breast cancer therapeutics in 2023 (estimate)
07
43,700 estimated breast cancer deaths in the United States in 2024.
Interpretation
Industry Overview Interpretation
For Industry Overview, breast cancer is not only widespread but also heavily backed by spending and markets, with the United States estimated to spend about $25.6 billion annually on care and global breast cancer diagnostics and therapeutics reaching roughly $8.7 billion and $14.2 billion in 2023.
report visual · Comparison
Key gaps and reach in breast cancer screening
Screening awareness and uptake remain uneven, with a substantial portion of eligible women not receiving recommended mammography.
76% of women aged 50–74 in the United States were up to date with recommended mammography screening in 2021.76%
69.2% of women aged 50–74 in the United States received a mammogram within the past 2 years (behavioral indicator from B
69.2%
34% of women are screened for breast cancer with a mammogram within the recommended interval (US, 2020 survey-based meas
34%
27% of women who are eligible for screening mammography do not receive it (US survey gap estimate)
27%
source-verifiedcdc.gov · nccn.org2021
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Marcus Afolabi. (2026, February 13). Breast Cancer Awareness Month Statistics. Gitnux. https://gitnux.org/breast-cancer-awareness-month-statistics
MLA
Marcus Afolabi. "Breast Cancer Awareness Month Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/breast-cancer-awareness-month-statistics.
Chicago
Marcus Afolabi. 2026. "Breast Cancer Awareness Month Statistics." Gitnux. https://gitnux.org/breast-cancer-awareness-month-statistics.
Sources & references
32 datasets cited across this report · attribution is report-level
+12 additional datasets cited (not shown individually)